Economic Burden of Eosinophilic Esophagitis: A Nationwide Cost-of-Illness Study.

Abstract

Despite its increasing prevalence, the economic impact of eosinophilic esophagitis (EoE) is understudied. We estimated the societal economic burden of EoE by using real-world data from Swedish health registers. EoE patients had 45% higher societal cost ($6,290 vs. $4,349) compared with the general population, primarily driven by increased healthcare costs ($2,414 vs. $1,022) which accounted for 72% of the excess societal cost in EoE. EoE is associated with a considerable economic burden to society. With the prevalence of EoE still rising, the economic burden of EoE is expected to continue to grow.